Antianxiety effect of cannabidiol in the elevated plus-maze

Guimarães, F. S., Chiaretti, T. M., Graeff, F. G., Zuardi, A. W.·1990·Psychopharmacology

DOI 10.1007/bf02244012

Cited by (378)

Items 101–200 of 378

Cannabidiol exhibits anxiolytic but not antipsychotic property evaluated in the social interaction test
Valéria de Almeida, Raquel R. Levin, Fernanda Fiel Peres, Suzy Tamie Niigaki, Mariana Bendlin Calzavara, Antônio Waldo Zuardi, Jaime E. C. Hallak, José Alexandre S. Crippa, Vanessa Costhek Abílio · 2012 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
Cannabidiol does not display drug abuse potential in mice behavior
Adrián Viudez‐Martínez, María S. García‐Gutiérrez, Juan Medrano-Relinque, Carmen M. Navarrón, Francisco Navarrete, Jorge Manzanares · 2018 · Acta Pharmacologica Sinica
Cannabinoid-related Agents in the Treatment of Anxiety Disorders: Current Knowledge and Future Perspectives
Simone Tambaro, Marco Bortolato · 2011 · Recent Patents on CNS Drug Discovery
Anxiolytic effect of cannabidiol derivatives in the elevated plus-maze
Francisco Silveira Guimarães, J. C. De Aguiar, Raphael Mechoulam, Aviva Breuer · 1994 · General Pharmacology The Vascular System
Cannabidiol attenuates behavioral changes in a rodent model of schizophrenia through 5-HT1A, but not CB1 and CB2 receptors
Naielly Rodrigues da Silva, Felipe Villela Gomes, Andreza Buzolin Sonego, Nicole Rodrigues da Silva, Francisco Silveira Guimarães · 2020 · Pharmacological Research
Cannabis and its constituents for cancer: History, biogenesis, chemistry and pharmacological activities
Samridhi Lal, Anusmita Shekher, Puneet, Acharan Singh Narula, Heidi Abrahamse, Subash C. Gupta · 2020 · Pharmacological Research
Administration of cannabidiol and imipramine induces antidepressant-like effects in the forced swimming test and increases brain-derived neurotrophic factor levels in the rat amygdala
Réus, Gislaine Z., Stringari, Roberto B., Ribeiro, Karine F., Luft, Tatiana, Abelaira, Helena M., Fries, Gabriel R., Aguiar, Bianca W., Kapczinski, Flávio, Hallak, Jaime E., Zuardi, Antônio W. et al. · 2011 · Acta Neuropsychiatrica
Acute Cannabinoids Produce Robust Anxiety-Like and Locomotor Effects in Mice, but Long-Term Consequences Are Age- and Sex-Dependent
Chelsea R. Kasten, Yanping Zhang, Stephen L. Boehm · 2019 · Frontiers in Behavioral Neuroscience
Endocannabinoids, cannabinoids and the regulation of anxiety
Gavin N. Petrie, Andrei S. Nastase, Robert J. Aukema, Matthew N. Hill · 2021 · Neuropharmacology
Uso terapêutico dos canabinoides em psiquiatria
José Alexandre S. Crippa, Antônio Waldo Zuardi, Jaime E. C. Hallak · 2010 · Brazilian Journal of Psychiatry
Interaction between cannabidiol (CBD) and ∆9-tetrahydrocannabinol (THC): influence of administration interval and dose ratio between the cannabinoids
Zuardi, Antonio Waldo, Hallak, Jaime Eduardo Cecílio, Crippa, José Alexandre S. · 2012 · Psychopharmacology
Use of Cannabidiol for the Treatment of Anxiety: A Short Synthesis of Pre-Clinical and Clinical Evidence
Madison Wright, Patricia Di Ciano, Bruna Brands · 2020 · Cannabis and Cannabinoid Research
Effects of cannabidiol on amphetamine-induced oxidative stress generation in an animal model of mania
Valvassori, Samira S, Elias, Guilherme, de Souza, Bruna, Petronilho, Fabrícia, Dal-Pizzol, Felipe, Kapczinski, Flávio, Trzesniak, Clarissa, Tumas, Vitor, Dursun, Serdar, Nisihara Chagas, Marcos Hortes et al. · 2011 · Journal of Psychopharmacology
Therapeutic and clinical foundations of cannabidiol therapy for difficult-to-treat seizures in children and adults with refractory epilepsies
Doodipala Samba Reddy · 2022 · Experimental Neurology
Rutin Improves Anxiety and Reserpine-Induced Depression in Rats
Ahmed Ibrahim Foudah, Mohammed Hamed Alqarni, Aftab Alam, Sushma Devi, Mohammad Ayman Salkini, Prawez Alam · 2022 · Molecules
Anxiolytic-like effects of Kava-Kava in the elevated plus maze test—a comparison with diazepam
André Rex, E. Morgenstern, Heidrun Fink · 2002 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
Beyond the CB1 Receptor: Is Cannabidiol the Answer for Disorders of Motivation?
Natalie E. Zlebnik, Joseph F. Cheer · 2016 · Annual Review of Neuroscience
Cannabidiol Prevents Motor and Cognitive Impairments Induced by Reserpine in Rats
Fernanda Fiel Peres, Raquel R. Levin, Mayra Akimi Suiama, Mariana Cepollaro Diana, Douglas Albuquerque Gouvêa, Valéria de Almeida, Camila M. Santos, Lisandro Lungato, Antônio Waldo Zuardi, Jaime E. C. Hallak et al. · 2016 · Frontiers in Pharmacology
Protective Effects of Cannabidiol against Seizures and Neuronal Death in a Rat Model of Mesial Temporal Lobe Epilepsy
Raquel A. Do Val-da Silva, José Eduardo Peixoto-Santos, Ludmyla Kandratavicius, Jana Batista De Ross, Ingrid M. Esteves, Bruno Spinosa De Martinis, Marcela Nogueira Rabelo Alves, Renata Caldo Scandiuzzi, Jaime E. C. Hallak, Antônio Waldo Zuardi et al. · 2017 · Frontiers in Pharmacology
Effects of coadministration of cannabinoids and morphine on nociceptive behaviour, brain monoamines and HPA axis activity in a rat model of persistent pain
David P. Finn, Simon R. G. Beckett, C. H. Roe, Ameneh Madjd, Kevin C.F. Fone, D. A. Kendall, Charles Alexander Marsden, Victoria Chapman · 2004 · European Journal of Neuroscience
Role of Cannabidiol in the Therapeutic Intervention for Substance Use Disorders
Francisco Navarrete, María S. García‐Gutiérrez, Ani Gasparyan, Amaya Austrich-Olivares, Jorge Manzanares · 2021 · Frontiers in Pharmacology
Effect of prior foot shock stress and Δ9-tetrahydrocannabinol, cannabidiolic acid, and cannabidiol on anxiety-like responding in the light-dark emergence test in rats
Erin M. Rock, Cheryl L. Limebeer, Gavin N. Petrie, Lauren A. Williams, Raphael Mechoulam, Linda A. Parker · 2017 · Psychopharmacology
The effects of cannabidiol on persecutory ideation and anxiety in a high trait paranoid group
Harneet Hundal, Rachel Lister, Nicole Evans, Angus Antley, Amir Englund, Robin M. Murray, Daniel H. Freeman, Paul D. Morrison · 2017 · Journal of Psychopharmacology
Cannabidiol effectively reverses mechanical and thermal allodynia, hyperalgesia, and anxious behaviors in a neuropathic pain model: Possible role of CB1 and TRPV1 receptors
Gleice Kelli Silva-Cardoso, Willian Lazarini-Lopes, Jaime E. C. Hallak, José Alexandre S. Crippa, Antônio Waldo Zuardi, Norberto Garcia‐Cairasco, Christie Ramos Andrade Leite‐Panissi · 2021 · Neuropharmacology
Modulation of Astrocyte Activity by Cannabidiol, a Nonpsychoactive Cannabinoid
Ewa Kozela, Ana Juknat, Zvi Vogel · 2017 · International Journal of Molecular Sciences
Towards cannabinoid drugs – revisited
Raphael Mechoulam, Lumir Ondrej Hanus, Ester Fride · 1998 · Progress in medicinal chemistry
Effects of intra-infralimbic prefrontal cortex injections of cannabidiol in the modulation of emotional behaviors in rats: Contribution of 5HT1A receptors and stressful experiences
Marinho, A.L.Z., Vila-Verde, C., Fogaça, M.V., Guimarães, F.S. · 2015 · Behavioural Brain Research
Development of a simple and sensitive HPLC–UV method for the simultaneous determination of cannabidiol and Δ9-tetrahydrocannabinol in rat plasma
Atheer Zgair, Jonathan C.M. Wong, Akmal Hidayat Bin Sabri, Peter M. Fischer, David A. Barrett, Cris S. Constantinescu, Pavel Gershkovich · 2015 · Journal of Pharmaceutical and Biomedical Analysis
The endocannabinoid system in the regulation of emotions throughout lifespan: a discussion on therapeutic perspectives
Eva María Marco, Giovanni Laviola · 2011 · Journal of Psychopharmacology
Cannabidiol reverses the mCPP ‐induced increase in marble‐burying behavior
Mirella Nardo, Plinio Cabrera Casarotto, Felipe V. Gomes, Francisco Silveira Guimarães · 2013 · Fundamental and Clinical Pharmacology
Effects of cannabidiol plus naltrexone on motivation and ethanol consumption
Adrián Viudez‐Martínez, María S. García‐Gutiérrez, Ana Isabel Fraguas‐Sánchez, Ana Isabel Torres‐Suárez, Jorge Manzanares · 2018 · British Journal of Pharmacology
Involvement of serotonin-mediated neurotransmission in the dorsal periaqueductal gray matter on cannabidiol chronic effects in panic-like responses in rats
Campos, Alline Cristina, de Paula Soares, Vanessa, Carvalho, Milene C, Ferreira, Frederico Rogerio, Vicente, Maria Adrielle, Brandão, Marcus Lira, Zuardi, Antonio Waldo, Zangrossi, Hélio, Guimarães, Francisco Silveira · 2013 · Psychopharmacology
Cannabinoid tetrad effects of oral Δ9-tetrahydrocannabinol (THC) and cannabidiol (CBD) in male and female rats: sex, dose-effects and time course evaluations
Catherine F. Moore, Elise M. Weerts · 2021 · Psychopharmacology
Transdermal delivery of cannabidiol attenuates binge alcohol-induced neurodegeneration in a rodent model of an alcohol use disorder
Daniel J. Liput, Dana C. Hammell, Audra L. Stinchcomb, Kimberly Nixon · 2013 · Pharmacology Biochemistry and Behavior
Antiaversive Effects of Cannabinoids: Is the Periaqueductal Gray Involved?
Fabrício A. Moreira, Daniele Cristina de Aguiar, Alline Cristina Campos, Sabrina Francesca de Souza Lisboa, Ana Luisa B. Terzian, Leonardo B.M. Resstel, Francisco Silveira Guimarães · 2008 · Neural Plasticity
Anxiolytic-like effects of obovatol isolated from Magnolia obovata: Involvement of GABA/benzodiazepine receptors complex
Jeong-Ju Seo, Seungho Lee, Yong-Su Lee, Byoung‐Mok Kwon, Yuan Ma, Bang‐Yeon Hwang, Jin Tae Hong, Ki‐Wan Oh · 2007 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
Cannabidiol inhibits the hyperphagia induced by cannabinoid-1 or serotonin-1A receptor agonists
América Augusto Scopinho, Francisco Silveira Guimarães, Fernando Morgan de Aguiar Corrêa, Leonardo B.M. Resstel · 2011 · Pharmacology Biochemistry and Behavior
Fluorinated Cannabidiol Derivatives: Enhancement of Activity in Mice Models Predictive of Anxiolytic, Antidepressant and Antipsychotic Effects
Aviva Breuer, Christeene G. Haj, Manoela V. Fogaça, Felipe V. Gomes, Nicole Rodrigues da Silva, João Francisco Cordeiro Pedrazzi, Elaine Aparecida Del Bel, Jaime E. C. Hallak, José A. Crippa, Antônio Waldo Zuardi et al. · 2016 · PLoS ONE
Tetrahydrocannabinol and cannabidiol medicines for chronic pain and mental health conditions
Jeremy David Henson, Luis Vitetta, Sean Hall · 2022 · Inflammopharmacology
Cannabidiol and brain function: current knowledge and future perspectives
Moniek Schouten, Sebastiaan Dalle, Dante Mantini, Katrien Koppo · 2024 · Frontiers in Pharmacology
Cannabidiol for the treatment of crack-cocaine craving: an exploratory double-blind study
Carolina de Meneses-Gaya, José Alexandre S. Crippa, Jaime E. C. Hallak, André Constantino Miguel, Ronaldo Laranjeira, Rodrigo A. Bressan, Antônio Waldo Zuardi, Acioly L.T. Lacerda · 2020 · Brazilian Journal of Psychiatry
Cannabidiol attenuates seizures and EEG abnormalities in Angelman syndrome model mice
Bin Gu, Manhua Zhu, Madison R. Glass, Marie Rougié, Viktoriya D. Nikolova, Sheryl S. Moy, Paul Richard Carney, Benjamin D. Philpot · 2019 · Journal of Clinical Investigation
Cannabidiol in the prelimbic cortex modulates the comorbid condition between the chronic neuropathic pain and depression-like behaviour in rats: The role of medial prefrontal cortex 5-HT1A and CB1 receptors
Rafael Braghetto Malvestio, Priscila Sanjuan de Medeiros, Sylmara Esther Negrini-Ferrari, Mariana Oliveira-Silva, Ana Carolina Medeiros, Cláudia Maria Padovan, Livio Luongo, Sabatino Maione, Norberto Cysne Coimbra, Renato Leonardo de Freitas · 2021 · Brain Research Bulletin
Cannabidiol Regulation of Learned Fear: Implications for Treating Anxiety-Related Disorders
Regimantas Jurkus, Harriet L. L. Day, Francisco Silveira Guimarães, Jonathan L. C. Lee, Leandro Jose Bertoglio, Carl W. Stevenson · 2016 · Frontiers in Pharmacology
Prolonged Cannabidiol Treatment Lacks on Detrimental Effects on Memory, Motor Performance and Anxiety in C57BL/6J Mice
Eva Maria Schleicher, Frederik Wilhelm Ott, Melanie Müller, Barbara Silcher, Marius E. Sichler, Maximilian Johannes Löw, Jannek M. Wagner, Yvonne Bouter · 2019 · Frontiers in Behavioral Neuroscience
The Divergent Effects of CDPPB and Cannabidiol on Fear Extinction and Anxiety in a Predator Scent Stress Model of PTSD in Rats
John Shallcross, Peter U. Hámor, Allison R. Bechard, Madison Romano, Lori A. Knackstedt, Marek Schwendt · 2019 · Frontiers in Behavioral Neuroscience
The role of 5-HT 1A receptors in the anti-aversive effects of cannabidiol on panic attack-like behaviors evoked in the presence of the wild snake Epicrates cenchria crassus (Reptilia, Boidae)
André Twardowschy, Maria Angélica Castiblanco-Urbina, A. Uribe-Mariño, Audrey Franceschi Biagioni, Carlos José Salgado-Rohner, José Alexandre S. Crippa, Norberto Cysne Coimbra · 2013 · Journal of Psychopharmacology
Cannabis and the Anxiety of Fragmentation—A Systems Approach for Finding an Anxiolytic Cannabis Chemotype
Brishna Kamal, Fatima Kamal, Daniel Lantela · 2018 · Frontiers in Neuroscience
Differential role of CB1 and TRPV1 receptors on anandamide modulation of defensive responses induced by nitric oxide in the dorsolateral periaqueductal gray
Sabrina Francesca de Souza Lisboa, Francisco Silveira Guimarães · 2012 · Neuropharmacology
Effects of intracisternal administration of cannabidiol on the cardiovascular and behavioral responses to acute restraint stress
Érica Maria Granjeiro, Felipe V. Gomes, Francisco Silveira Guimarães, Fernando Morgan de Aguiar Corrêa, Leonardo B.M. Resstel · 2011 · Pharmacology Biochemistry and Behavior
Cannabidiol Is a Potential Therapeutic for the Affective-Motivational Dimension of Incision Pain in Rats
Karina Genaro, Débora Fabris, Ana Luisa Ferreira Arantes, Antônio Waldo Zuardi, José Alexandre S. Crippa, Wiliam A. Prado · 2017 · Frontiers in Pharmacology
Cannabidiol Administered During Peri-Adolescence Prevents Behavioral Abnormalities in an Animal Model of Schizophrenia
Fernanda Fiel Peres, Mariana Cepollaro Diana, Raquel R. Levin, Mayra Akimi Suiama, Valéria de Almeida, Ana Maria Vendramini, Camila M. Santos, Antônio Waldo Zuardi, Jaime E. C. Hallak, José Alexandre S. Crippa et al. · 2018 · Frontiers in Pharmacology
“Anxiolytic” action of diazepam and abecarnil in a modified open field test
André Rex · 1996 · Pharmacology Biochemistry and Behavior
Therapeutic Prospects of Cannabidiol for Alcohol Use Disorder and Alcohol-Related Damages on the Liver and the Brain
Julia de Ternay, Mickaël Naassïla, Mikaïl Nourredine, Alexandre Louvet, François Bailly, Guillaume Sescousse, Pierre Maurage, Olivier Cottencin, Patrizia Carrieri, Benjamin Rolland · 2019 · Frontiers in Pharmacology
Effects of an acute cannabidiol treatment on cocaine self-administration and cue-induced cocaine seeking in male rats
Ashraf Mahmud, Stephanie Gallant, Firas Sedki, Tracey M. D’Cunha, Uri Shalev · 2016 · Journal of Psychopharmacology
Antinociceptive effects of HUF-101, a fluorinated cannabidiol derivative
Nicole Rodrigues da Silva, Felipe V. Gomes, Miriam M. Fonseca, Raphael Mechoulam, Aviva Breuer, Thiago M. Cunha, Francisco Silveira Guimarães · 2017 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
Cannabinoid CB1 Receptor Involvement in the Actions of CBD on Anxiety and Coping Behaviors in Mice
Amaya Austrich-Olivares, María S. García‐Gutiérrez, Lucía Illescas, Ani Gasparyan, Jorge Manzanares · 2022 · Pharmaceuticals
Citral Inhibits the Inflammatory Response and Hyperalgesia in Mice: The Role of TLR4, TLR2/Dectin-1, and CB2 Cannabinoid Receptor/ATP-Sensitive K+ Channel Pathways
Elaine Cristina Dalazen Gonçalves, Pollyana Mendonça de Assis, Laura Andrade Junqueira, Maíra Cola, Adair R.S. Santos, Nádia Rezende Barbosa Raposo, Rafael Cypriano Dutra · 2020 · Journal of Natural Products
Cannabidiol for the treatment of autism spectrum disorder: hope or hype?
João Francisco Cordeiro Pedrazzi, Frederico Rogério Ferreira, Danyelle Silva-Amaral, Daniel de Alencar Lima, Jaime E. C. Hallak, Antônio Waldo Zuardi, Elaine Aparecida Del Bel, Francisco Silveira Guimarães, Karla Cristinne Mancini Costa, Alline Cristina Campos et al. · 2022 · Psychopharmacology
THC and CBD: Villain versus Hero? Insights into Adolescent Exposure
Nicholas Pintori, Francesca Caria, Maria Antonietta De Luca, Cristina Miliano · 2023 · International Journal of Molecular Sciences
Role of the Endocannabinoid System in the Pathophysiology of Schizophrenia: Implications for Pharmacological Intervention
F. Markus Leweke, Juliane K. Mueller, Bettina Lange, Stefan Fritze, Cristina E. Topor, Dagmar Koethe, Cathrin Rohleder · 2018 · CNS Drugs
Cannabidiol for the Treatment of Brain Disorders: Therapeutic Potential and Routes of Administration
Grace Tsz Yan Yau, Waiting Tai, Jonathon Carl Arnold, Hak‐Kim Chan, Philip Chi Lip Kwok · 2023 · Pharmaceutical Research
Cannabinoid Actions on Neural Stem Cells: Implications for Pathophysiology
R. Rodrigues, D. Lourenço, S. Paulo, J. Mateus, M. A. Ferreira, Francisco M. Mouro, J. B. Moreira, F. Ribeiro, A. Sebastião, S. Xapelli · 2019 · Molecules
Gender differences in the effects of cannabidiol on ethanol binge drinking in mice
Adrián Viudez‐Martínez, María S. García‐Gutiérrez, Jorge Manzanares · 2019 · Addiction Biology
The nonpsychoactive cannabis constituent cannabidiol is a wake-inducing agent.
Eric Murillo‐Rodríguez, Diana Millán‐Aldaco, Marcela Palomero‐Rivero, Raphael Mechoulam, René Drucker-Colı́n · 2008 · Behavioral Neuroscience
The Yin and Yang of Cannabis-induced Psychosis: the Actions of Δ 9-Tetrahydrocannabinol and Cannabidiol in Rodent Models of Schizophrenia
Jonathon Carl Arnold, A.A. Boucher, Tim Karl · 2012 · Current Pharmaceutical Design
Cannabidiol regulates the expression of hypothalamus-pituitary-adrenal axis-related genes in response to acute restraint stress
Adrián Viudez‐Martínez, María S. García‐Gutiérrez, Jorge Manzanares · 2018 · Journal of Psychopharmacology
Maternal and Fetal Pharmacokinetic Analysis of Cannabidiol during Pregnancy in Mice
Wataru Ochiai, Satoshi Kitaoka, Taisuke Kawamura, Jo Hatogai, Shohei Harada, Misa Iizuka, Mashu Ariumi, Seiya Takano, Tomomi Nagai, Masanaho Sasatsu et al. · 2021 · Drug Metabolism and Disposition
Scientific Validation of Cannabidiol for Management of Dog and Cat Diseases
Isabella Corsato Alvarenga, Kiran S. Panickar, Hannah Hess, Stephanie McGrath · 2023 · Annual Review of Animal Biosciences
Protective Effects of Cannabidiol on Lesion-Induced Intervertebral Disc Degeneration
J.W.S. Silveira, Ana Carolina Issy, Vitor Castania, Carlos Ernesto Garrido Salmón, Marcello Henrique Nogueira‐Barbosa, Francisco Silveira Guimarães, Helton Luíz Aparecido Defino, Elaine Aparecida Del Bel · 2014 · PLoS ONE
Analysis of the Uptake, Metabolism, and Behavioral Effects of Cannabinoids on Zebrafish Larvae
John C. Achenbach, Jessica Hill, Joseph P. M. Hui, Michael G. Morash, Fabrice Berrué, Lee D. Ellis · 2018 · Zebrafish
New Perspectives on the Use of Cannabis in the Treatment of Psychiatric Disorders
María Scherma, Paolo Masia, Matteo Luca Deidda, Walter Fratta, Gianluigi Tanda, Paola Fadda · 2018 · Medicines
Glial Cells and Their Contribution to the Mechanisms of Action of Cannabidiol in Neuropsychiatric Disorders
Franciele Franco Scarante, Melissa A. Ribeiro, Ana Flávia Almeida-Santos, Francisco Silveira Guimarães, Alline Cristina Campos · 2021 · Frontiers in Pharmacology
Sex-dependent differences in the anxiolytic-like effect of cannabidiol in the elevated plus-maze
Débora Fabris, M. C. Carvalho, M. Brandão, W. A. Prado, A. Zuardi, J. Crippa, A. D. de Oliveira, T. Lovick, K. Genaro · 2022 · Journal of Psychopharmacology
Sativex Associated With Behavioral-Relapse Prevention Strategy as Treatment for Cannabis Dependence
Jose M. Trigo, Alexandra Soliman, Gregory Staios, Lena Catherine Quilty, Benedikt Fischer, Tony Peter George, Jürgen T. Rehm, Peter L. Selby, Allan J. Barnes, Marilyn Ann Huestis et al. · 2016 · Journal of Addiction Medicine
Modulation of the Endocannabinoid System: Vulnerability Factor and New Treatment Target for Stimulant Addiction
Stéphanie Olière, Antoine Joliette-Riopel, Stéphane Potvin, Didier Jutras‐Aswad · 2013 · Frontiers in Psychiatry
Palmitoylethanolamide: A Potential Alternative to Cannabidiol
Paul Clayton, Silma Subah, Ruchitha Venkatesh, Mariko Hill, Nathasha Omal Bogoda · 2021 · Journal of Dietary Supplements
Decoding the Mechanism of Action of Rapid-Acting Antidepressant Treatment Strategies: Does Gender Matter?
David P. Herzog, Gregers Wegener, Klaus Lieb, Marianne B. Müller, Giulia Treccani · 2019 · International Journal of Molecular Sciences
UK Medical Cannabis Registry: an analysis of clinical outcomes of medicinal cannabis therapy for generalized anxiety disorder
Mehmet Ergisi, Simon Erridge, Michael Harris, Michal Kawka, Devaki Nimalan, Oliver Salazar, Katerina Loupasaki, Rayyan Ali, Carl Holvey, Ross Coomber et al. · 2021 · Expert Review of Clinical Pharmacology
Anxiogenic-like effects induced by hemopressin in rats
Manoela V. Fogaça, Andreza Buzolin Sonego, Vanessa Rioli, Fabio Cesar Gozzo, Camila Squarzoni Dale, Emer Suavinho Ferro, Francisco Silveira Guimarães · 2014 · Pharmacology Biochemistry and Behavior
Effects of cannabidiol on symptoms induced by the recall of traumatic events in patients with posttraumatic stress disorder
Lívia Maria Bolsoni, José Alexandre S. Crippa, Jaime E. C. Hallak, Francisco Silveira Guimarães, Antônio Waldo Zuardi · 2022 · Psychopharmacology
Cannabinoid treatments for anxiety: A systematic review and consideration of the impact of sleep disturbance
Andrea J. Narayan, Luke A. Downey, Brooke Manning, Amie C. Hayley · 2022 · Neuroscience & Biobehavioral Reviews
The Management of Cancer Symptoms and Treatment-Induced Side Effects With Cannabis or Cannabinoids
Michelle Sexton, José M. Garcia, Aminah Jatoi, Carey S. Clark, Mark S. Wallace · 2021 · JNCI Monographs
Two-weeks treatment with cannabidiol improves biophysical and behavioral deficits associated with experimental type-1 diabetes
Yane Costa Chaves, Karina Genaro, Cristina Aparecida Jark Stern, Gisele de Oliveira Guaita, José Alexandre S. Crippa, Joice Maria da Cunha, Janaína Menezes Zanoveli · 2020 · Neuroscience Letters
Female but not male rats show biphasic effects of low doses of Δ9-tetrahydrocannabinol on anxiety: can cannabidiol interfere with these effects?
Beatriz Zanutto Salviato, Ana Maria Raymundi, Thiago Rodrigues da Silva, Bruna Wuilleumier Salemme, Jeferson Machado Batista Sohn, Fabiano Soares de Araujo, Francisco Silveira Guimarães, Leandro Jose Bertoglio, Cristina Aparecida Jark Stern · 2021 · Neuropharmacology
Pain and U-Shaped Dose Responses: Occurrence, Mechanisms, and Clinical Implications
Edward J. Calabrese · 2008 · Critical Reviews in Toxicology
Lantana camara leaf extract ameliorates memory deficit and the neuroinflammation associated with scopolamine-induced Alzheimer’s-like cognitive impairment in zebrafish and mice
Veronica Amoah, Paul Atawuchugi, Jibira Yakubu, Augustine Tandoh, Paul Poku Sampene Ossei, George Henry Sam ., George K. Ainooson · 2023 · Pharmaceutical Biology
Dissociation between the panicolytic effect of cannabidiol microinjected into the substantia nigra, pars reticulata, and fear-induced antinociception elicited by bicuculline administration in deep layers of the superior colliculus: The role of CB1-cannabinoid receptor in the ventral mesencephalon
Juliana Almeida da Silva, Audrey Franceschi Biagioni, Rafael Carvalho Almada, José Alexandre S. Crippa, Jaime E. C. Hallak, Antônio Waldo Zuardi, Norberto Cysne Coimbra · 2015 · European Journal of Pharmacology
Oxycodone decreases anxiety-like behavior in the elevated plus-maze test in male and female rats
Adriaan W. Bruijnzeel, Azin Behnood‐Rod, Wendi L. Malphurs, Ranjithkumar Chellian, Robert M. Caudle, Marcelo Febo, Barry Setlow, John K. Neubert · 2022 · Behavioural Pharmacology
Evaluation of the potential use of cannabidiol in the treatment of cocaine use disorder: A systematic review
Larissa Alencar Rodrigues, Mariana Emanuele Silva Caroba, Fernando Kengy Taba, Renato Filev, Andréa Donatti Gallassi · 2020 · Pharmacology Biochemistry and Behavior
Cannabidiol (CBD) treatment improves spatial memory in 14-month-old female TAU58/2 transgenic mice
Fabian Kreilaus, Magdalena Przybyla, Lars Matthias Ittner, Tim Karl · 2022 · Behavioural Brain Research
Drug effects on responses to emotional facial expressions
Melissa A. Miller, Anya K. Bershad, Harriet de Wit · 2015 · Behavioural Pharmacology
Assessing the role of serotonergic receptors in cannabidiol's anticonvulsant efficacy
Madeline C. Pelz, Kathleen D. Schoolcraft, Chloe S. Larson, Mitchell G. Spring, Hassan H. López · 2017 · Epilepsy & Behavior
Cannabinoid Geometry and Biological Activity
Raphael Mechoulam, William A. Devane, Rainer Glaser · 1999 · Humana Press eBooks
Single and combined effects of plant‐derived and synthetic cannabinoids on cognition and cannabinoid‐associated withdrawal signs in mice
Alyssa M Myers, Patrick B Siegele, Jeffrey D Foss, Ronald F. Tuma, Sara Jane Ward · 2018 · British Journal of Pharmacology
Differentiation of industrial hemp strains by their cannabinoid and phenolic compounds using LC × LC-HRMS
Lidia Montero, Sven W. Meckelmann, Hyerin Kim, Juan Francisco Ayala-Cabrera, Oliver Johannes Schmitz · 2022 · Analytical and Bioanalytical Chemistry
Cannabis use and symptoms of anxiety in adolescence and the moderating effect of the serotonin transporter gene
Roy Otten, Anja C. Huizink, Karin Monshouwer, Hanneke E. Creemers, Simone Arianne Onrust · 2016 · Addiction Biology
Cannabidiol Induces Cytotoxicity and Cell Death via Apoptotic Pathway in Cancer Cell Lines
Won-HyungHyun-Do ChoiPark, Seung‐Hwa Baek, Jong‐Phil Chu, Mae-Hwa Kang, Yu-Jing Mi · 2008 · Biomolecules & Therapeutics
Differential effects of CB1 receptor agonism in behavioural tests of unconditioned and conditioned fear in adult male rats
Jonathan J. Simone, Matthew R. Green, Travis E. Hodges, Cheryl M. McCormick · 2014 · Behavioural Brain Research
Hippocampal mammalian target of rapamycin is implicated in stress-coping behavior induced by cannabidiol in the forced swim test
Ariandra Guerini Sartim, Amanda J. Sales, Francisco Silveira Guimarães, Sâmia R.L. Joca · 2018 · Journal of Psychopharmacology